GO:1903532 positive regulation of secretion by cell: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1903532 (positive regulation of secretion by cell) describes any process that activates or increases the frequency, rate, or extent of secretion by a cell.
• It is a biological_process term that sits upstream of vesicle docking, fusion, and cargo release, integrating signals from nutrients, hormones, and immune receptors [1,2,3].
• Key regulatory nodes include mTOR, Lyn, Itk, TDP-43, and proprotein convertases PC1/3 and PC2, which tune secretion in pancreatic beta cells, mast cells, NK cells, and mammary epithelial cells [2,3,4,5,6].
• Dysregulation of positive regulation of secretion by cell contributes to type 2 diabetes, immune disorders, and secretory defects in lactation and neuroendocrine tissues [3,6,7,8].
• CRISPR knockout, point-mutation, knock-in, and overexpression models are essential to dissect causal roles of candidate regulators in secretion [3,4,6,8].
• EDITGENE provides end-to-end CRISPR cell model and library screening services to study positive regulation of secretion by cell at scale.
Description
Positive regulation of secretion by cell (GO:1903532) is a Gene Ontology biological_process term that captures any mechanism which activates or increases the frequency, rate, or extent of secretion by a cell. Secretion is fundamental to intercellular communication, nutrient handling, immune defense, and tissue remodeling, and its positive control ensures that hormones, neurotransmitters, cytokines, and lipids are released at the right time and amount [1,2,3]. Researchers study this term because its dysregulation underlies common diseases such as type 2 diabetes, immune dyscrasias, and secretory epithelial disorders [3,6,7]. The ontology term deliberately focuses on the regulatory input rather than the core secretory machinery, making it a powerful entry point for identifying upstream signaling nodes that can be targeted experimentally [1,2,5]. Because positive regulation of secretion by cell is defined by its effect on secretion, it encompasses diverse molecular mechanisms, including kinase cascades, transcriptional and post-transcriptional control, and metabolic sensing [2,3,6,8]. This article synthesizes authoritative QuickGO annotation and verified PubMed literature to explain what the term means, which genes implement it, how it is studied, and why it matters for human health.
positive regulation of secretion by cell At A Glance
| GO ID | GO:1903532 |
|---|---|
| GO term | positive regulation of secretion by cell |
| Ontology | biological_process |
| Synonym | activation of cellular secretion; activation of secretion by cell; positive regulation of cellular secretion; up regulation of cellular secretion; up-regulation of cellular secretion; upregulation of cellular secretion; up regulation of secretion by cell; up-regulation of secretion by cell; upregulation of secretion by cell |
| Major function | Activates or increases the frequency, rate, or extent of secretion by a cell |
| Biological context | Hormone release, immune mediator secretion, lipid secretion, neuroendocrine signaling |
| Regulatory inputs | Receptor tyrosine kinases, mTOR signaling, transcription factors, RNA-binding proteins, proprotein convertases |
| Disease relevance | Type 2 diabetes, immune disorders, secretory epithelial dysfunction, neurodegeneration-associated secretory defects |
What Is GO:1903532?
According to the QuickGO definition, GO:1903532 refers to any process that activates or increases the frequency, rate, or extent of secretion by cell. In practical terms, it is the positive arm of secretory control: signals that boost the release of cargo from a cell, whether that cargo is a hormone, a cytokine, a lipid, or a neurotransmitter. The term is a biological_process and is synonymous with activation of cellular secretion, positive regulation of cellular secretion, and upregulation of secretion by cell.
Why Is positive regulation of secretion by cell Important in Cell Biology?
Positive regulation of secretion by cell is important because it determines how cells communicate and respond to physiological demand. In pancreatic beta cells, positive regulation of insulin secretion is required for glucose homeostasis, and its failure contributes to type 2 diabetes [3,7,8]. In immune cells, positive regulation of mediator secretion shapes allergic and cytotoxic responses, as shown for Lyn in mast cells and Itk in NK cells [2,5]. In mammary epithelial cells, positive regulation of lipid secretion supports lactation, and its disruption affects neonatal nutrition. Because the term integrates diverse upstream signals, it provides a conceptual and experimental framework for identifying therapeutic targets that tune secretion without abolishing it [1,3,4].
• Controls hormone release, including insulin and glucagon-like peptides, which are central to metabolic health [3,4].
• Regulates immune mediator secretion in mast cells and NK cells, influencing allergy and cytotoxicity [2,5].
• Supports lipid secretion in mammary epithelial cells during lactation.
• Integrates nutrient sensing via mTOR to match secretory output with metabolic state.
• Involves post-transcriptional control by RNA-binding proteins such as TDP-43.
• Depends on proprotein convertases PC1/3 and PC2 for processing proglucagon peptides that modulate insulin secretion.
• Dysregulation is linked to type 2 diabetes and beta-cell demise [3,7].
• Provides candidate targets for therapeutic modulation of secretion in endocrine and immune disorders [1,2,5].
• Enables mechanistic dissection using CRISPR knockout and knock-in models [3,4,6,8].
• Supports high-throughput screening to discover new regulators of secretion [3,6].
What Happens During positive regulation of secretion by cell?
Signal reception and upstream activation
In simple terms: A cell receives a signal that tells it to release more cargo.
Positive regulation of secretion by cell begins when extracellular or intracellular cues activate receptors and signaling cascades. In pancreatic beta cells, nutrient and hormonal signals converge on mTOR to increase insulin secretion. In mast cells, Fc epsilon RI engagement recruits Lyn, which positively regulates activation and mediator release. In NK cells, the tyrosine kinase Itk differentially regulates cytotoxicity and secretory responses. These examples illustrate that the term encompasses diverse receptor-proximal events that ultimately enhance secretion [2,3,5].
Metabolic and nutrient sensing
In simple terms: The cell checks its energy status before releasing cargo.
mTOR signaling is a central node in the positive regulation of secretion by cell, particularly in pancreatic beta cells where it influences beta-cell mass and insulin secretion. Lipid droplets also participate in beta-cell function and demise, linking lipid metabolism to secretory regulation in type 2 diabetes. In mammary epithelial cells, TDP-43 facilitates milk lipid secretion by post-transcriptional regulation of Btn1a1 and Xdh, showing that RNA processing can positively regulate a specialized secretory program.
Cargo processing and maturation
In simple terms: The cargo must be cut and packaged correctly before it can be secreted.
Proprotein convertases PC1/3 and PC2 process proglucagon peptides in alpha cells, and this processing controls insulin secretion, demonstrating that positive regulation of secretion by cell can occur at the level of cargo maturation. Polyadenylation of insulin mRNA by Tent5a regulates pancreatic beta cells, adding a post-transcriptional layer that supports secretory output. These mechanisms ensure that the secreted product is bioactive and appropriately abundant [4,8].
Vesicle trafficking and release
In simple terms: Packaged cargo is moved to the cell surface and released.
Once cargo is processed, positive regulation of secretion by cell impinges on vesicle trafficking, docking, and fusion. Although the QuickGO definition does not specify individual trafficking steps, the literature shows that upstream regulators such as mTOR, Lyn, and Itk ultimately increase the frequency or extent of release [2,3,5]. In mammary epithelial cells, TDP-43-dependent regulation of Btn1a1 and Xdh supports lipid droplet secretion, illustrating how a single RNA-binding protein can orchestrate a secretory program.
Feedback and integration
In simple terms: The cell adjusts secretion based on ongoing signals.
Positive regulation of secretion by cell is not a one-way switch; it is integrated with negative feedback and metabolic status. Lyn has both positive and negative roles in mast cell activation, showing that the same kinase can tune the magnitude of secretion. mTOR integrates nutrient and growth signals to set the level of insulin secretion. This integration ensures that secretion matches physiological demand and prevents excessive release [2,3].
Key Genes Involved in GO:1903532 positive regulation of secretion by cell
The following genes and proteins have been experimentally linked to positive regulation of secretion by cell in the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| MTOR | Nutrient-sensitive kinase that promotes insulin secretion and beta-cell mass | Central regulator of secretion in pancreatic beta cells; target for diabetes research |
| LYN | Src-family kinase that positively and negatively regulates mast cell activation | Model for Fc epsilon RI-dependent secretion in allergy |
| ITK | Tyrosine kinase that differentially regulates NK cell cytotoxicity | Model for immune secretory responses |
| TARDBP | RNA-binding protein that facilitates milk lipid secretion | Links post-transcriptional control to lipid secretion |
| BTN1A1 | Milk lipid droplet-associated protein regulated by TDP-43 | Marker of mammary lipid secretion |
| XDH | Xanthine dehydrogenase regulated by TDP-43 | Supports milk lipid secretion |
| PCSK1 | Proprotein convertase PC1/3 that processes proglucagon | Controls alpha-cell peptide processing and insulin secretion |
| PCSK2 | Proprotein convertase PC2 that processes proglucagon | Controls alpha-cell peptide processing and insulin secretion |
| TENT5A | Polyadenylation factor for insulin mRNA | Regulates pancreatic beta-cell function |
| INS | Insulin cargo whose secretion is positively regulated | Readout of beta-cell secretory capacity [3,8] |
| GCG | Proglucagon-derived peptides that modulate insulin secretion | Links alpha-cell processing to beta-cell secretion |
| CCK | Cholecystokinin whose secretion is regulated by intraluminal factors | Model for nutrient-triggered secretion |
| FCER1A | High-affinity IgE receptor subunit in mast cells | Upstream of Lyn-mediated secretion |
| PLCG1 | Downstream signaling enzyme in immune secretion | Candidate node in positive regulation of secretion [2,5] |
| PRKCB | Protein kinase C beta involved in secretory signaling | Potential modulator of vesicle release |
| STXBP1 | Syntaxin-binding protein in vesicle fusion | Effector of secretory regulation |
| RAB27A | Rab GTPase in secretory granule trafficking | Effector of regulated secretion |
How Is positive regulation of secretion by cell Regulated?
Positive regulation of secretion by cell is controlled by layered signaling. mTOR integrates nutrient and growth factor inputs to promote insulin secretion and beta-cell mass. Lyn provides both positive and negative regulation of mast cell activation, illustrating feedback control. Itk differentially regulates NK cell cytotoxicity, showing that the same kinase can tune distinct secretory outputs. Post-transcriptional mechanisms, including TDP-43-dependent regulation of Btn1a1 and Xdh and Tent5a-mediated polyadenylation of insulin mRNA, add additional control layers [6,8]. Proprotein convertases PC1/3 and PC2 regulate the processing of proglucagon peptides that influence insulin secretion, linking cargo maturation to secretory output.
positive regulation of secretion by cell and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| MTOR | Type 2 diabetes, beta-cell dysfunction | Beta-cell-specific knockout or point-mutation models |
| LYN | Allergy, mast cell activation disorders | Mast cell knockout and knock-in models |
| ITK | Immune dysregulation, NK cell cytotoxicity defects | NK cell knockout models |
| TARDBP | Secretory epithelial dysfunction, lactation defects | Mammary epithelial knockout and overexpression models |
| TENT5A | Beta-cell dysfunction, insulin secretion defects | Beta-cell knockout and knock-in models |
Type 2 diabetes and beta-cell dysfunction
Positive regulation of secretion by cell is central to pancreatic beta-cell function. mTOR signaling influences beta-cell mass and insulin secretion, and its dysregulation contributes to type 2 diabetes. Lipid droplets play a role in beta-cell function and demise in type 2 diabetes, linking lipid metabolism to secretory failure. Polyadenylation of insulin mRNA by Tent5a regulates beta cells, and defects in this process can impair insulin production. Alpha-cell processing of proglucagon by PC1/3 and PC2 also controls insulin secretion, highlighting intercellular regulation within the islet.
Immune and allergic disorders
In mast cells, Lyn positively and negatively regulates Fc epsilon RI-dependent activation, and altered Lyn function can shift the balance of mediator secretion in allergic responses. In NK cells, Itk differentially regulates cytotoxicity, and perturbations in this pathway can affect immune surveillance. These examples show that positive regulation of secretion by cell is a determinant of immune response intensity.
Secretory epithelial and lactation disorders
TDP-43 facilitates milk lipid secretion by post-transcriptional regulation of Btn1a1 and Xdh, and disruption of this axis can impair lactation. This illustrates how positive regulation of secretion by cell extends beyond endocrine and immune cells to specialized secretory epithelia.
Neuroendocrine and gastrointestinal secretion
Cholecystokinin secretion is regulated by intraluminal releasing factors, providing a classic example of positive regulation of secretion by cell in the gut. This pathway is relevant to digestive physiology and nutrient sensing.
From positive regulation of secretion by cell-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is MTOR required for insulin secretion? | Beta-cell-specific mTOR knockout |
| Does Lyn positively regulate mast cell secretion? | Lyn knockout and point-mutation mast cells |
| How does Itk tune NK cell cytotoxicity? | Itk knockout NK cells |
| Does TDP-43 control milk lipid secretion? | TDP-43 knockout and overexpression in mammary epithelial cells |
| What is the role of Tent5a in insulin mRNA polyadenylation? | Tent5a knockout and knock-in beta cells |
| Do PC1/3 and PC2 process proglucagon to control insulin secretion? | Pcsk1/Pcsk2 knockout alpha cells |
How to Study the positive regulation of secretion by cell Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss-of-function effect on secretion | Test requirement of candidate genes [3,6] |
| CRISPR point mutation | Effect of specific residues on secretion | Dissect kinase domain functions [2,5] |
| CRISPR knock-in | Tagged or reporter allele function | Track endogenous protein localization [6,8] |
| Overexpression | Gain-of-function effect on secretion | Test sufficiency of regulators |
| Live-cell imaging | Vesicle trafficking and release dynamics | Localize secretory steps [3,6] |
| RNA-seq | Transcriptional changes in secretory cells | Identify downstream programs [6,8] |
| Phosphoproteomics | Signaling changes after perturbation | Map kinase cascades [2,3,5] |
| Proprotein convertase assay | Cargo processing efficiency | Assess PC1/3 and PC2 activity |
Genetic perturbation with CRISPR
CRISPR knockout, point-mutation, knock-in, and overexpression models allow causal testing of candidate regulators of positive regulation of secretion by cell. For example, beta-cell-specific knockout of mTOR can reveal its requirement for insulin secretion, while Lyn knockout and point-mutation models can dissect positive versus negative regulation in mast cells.
Secretory assays and live-cell imaging
Measuring cargo release, such as insulin or lipid droplets, provides a direct readout of positive regulation of secretion by cell. Live-cell imaging of vesicle trafficking and fusion can localize the step at which a regulator acts [3,6].
Transcriptomic and post-transcriptional profiling
RNA-seq and polyadenylation profiling can identify post-transcriptional mechanisms, such as Tent5a-mediated polyadenylation of insulin mRNA and TDP-43-dependent regulation of Btn1a1 and Xdh.
Proteomic and signaling analysis
Phosphoproteomics and kinase assays can map signaling cascades downstream of Lyn, Itk, and mTOR that converge on secretion [2,3,5]. Proprotein convertase activity assays can assess PC1/3 and PC2 function in proglucagon processing.
How CRISPR Can Be Used to Study GO:1903532 positive regulation of secretion by cell
Knockout
CRISPR knockout is used to delete candidate regulators and test whether they are required for positive regulation of secretion by cell. For example, knockout of mTOR in beta cells can reveal its role in insulin secretion, and knockout of Lyn can show its contribution to mast cell activation.
Point Mutation
Point mutations can dissect specific domains or residues. Lyn has both positive and negative roles in mast cell activation, and point mutations can separate these functions. Itk point mutations can reveal differential effects on NK cell cytotoxicity.
Knock-in
Knock-in of tagged or reporter alleles allows tracking of endogenous proteins involved in secretion. For example, tagging TDP-43 or Tent5a can reveal their localization and dynamics in secretory cells [6,8].
Overexpression
Overexpression tests whether a candidate gene is sufficient to increase secretion. Overexpression of TDP-43 or its targets can enhance milk lipid secretion in mammary epithelial cells, and overexpression of mTOR pathway components can boost insulin secretion.
How EDITGENE Supports positive regulation of secretion by cell Research
Researchers studying positive regulation of secretion by cell-related genes often need to determine whether a candidate gene is causally involved in secretion or merely correlated with it. CRISPR-based cell models provide the gold standard for this causal testing, enabling precise knockout, point mutation, knock-in, and overexpression in relevant cell types.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of secretion by cell research.
Frequently Asked Questions About positive regulation of secretion by cell
What is GO:1903532 positive regulation of secretion by cell?
It is a Gene Ontology biological_process term defined as any process that activates or increases the frequency, rate, or extent of secretion by cell.
What genes are involved in positive regulation of secretion by cell?
Key genes include MTOR, LYN, ITK, TARDBP, BTN1A1, XDH, PCSK1, PCSK2, and TENT5A, based on verified literature [2,3,4,5,6,8].
How does mTOR regulate secretion by cell?
mTOR integrates nutrient and growth signals to promote insulin secretion and beta-cell mass.
What is the role of Lyn in mast cell secretion?
Lyn positively and negatively regulates Fc epsilon RI-dependent mast cell activation and mediator release.
How does TDP-43 affect milk lipid secretion?
TDP-43 facilitates milk lipid secretion by post-transcriptional regulation of Btn1a1 and Xdh.
What is the function of PC1/3 and PC2 in secretion?
PC1/3 and PC2 process proglucagon peptides in alpha cells and control insulin secretion.
How is insulin mRNA polyadenylation regulated?
Tent5a mediates polyadenylation of insulin mRNA and regulates pancreatic beta cells.
What diseases are linked to positive regulation of secretion by cell?
Type 2 diabetes, immune disorders, and secretory epithelial dysfunction are linked to dysregulation of this process [2,3,6,7,8].
How can CRISPR be used to study positive regulation of secretion by cell?
CRISPR knockout, point mutation, knock-in, and overexpression models can test causal roles of candidate genes in secretion [2,3,4,6,8].
What methods measure positive regulation of secretion by cell?
Secretory assays, live-cell imaging, RNA-seq, phosphoproteomics, and proprotein convertase assays are commonly used [2,3,4,6,8].
Conclusion
Positive regulation of secretion by cell (GO:1903532) is a central biological process that integrates nutrient sensing, immune signaling, and post-transcriptional control to tune the release of hormones, cytokines, and lipids [1,2,3,6]. Its dysregulation contributes to type 2 diabetes, immune disorders, and secretory epithelial defects [3,6,7,8]. CRISPR-based models and multi-omics methods provide powerful tools to dissect the causal roles of genes such as MTOR, LYN, ITK, TARDBP, PCSK1, PCSK2, and TENT5A in this process [2,3,4,5,6,8]. Continued research will refine our understanding of how positive regulation of secretion by cell can be therapeutically modulated.
References
- 1. Liddle RA. 1995. Regulation of cholecystokinin secretion by intraluminal releasing factors.. Am J Physiol 269(3 Pt 1):G319-27 PMID: 7573441
- 2. Xiao W et al.. 2005. Positive and negative regulation of mast cell activation by Lyn via the FcepsilonRI.. J Immunol 175(10):6885-92 PMID: 16272347
- 3. Asahara SI et al.. 2022. Roles of mTOR in the Regulation of Pancreatic β-Cell Mass and Insulin Secretion.. Biomolecules 12(5) PMID: 35625542
- 4. Cui C et al.. 2025. α cells use both PC1/3 and PC2 to process proglucagon peptides and control insulin secretion.. Sci Adv 11(38):eady8048 PMID: 40971442
- 5. Khurana D et al.. 2007. Differential regulation of human NK cell-mediated cytotoxicity by the tyrosine kinase Itk.. J Immunol 178(6):3575-82 PMID: 17339454
- 6. Zhao L et al.. 2020. TDP-43 facilitates milk lipid secretion by post-transcriptional regulation of Btn1a1 and Xdh.. Nat Commun 11(1):341 PMID: 31953403
- 7. Tong X et al.. 2022. Lipid Droplets' Role in the Regulation of β-Cell Function and β-Cell Demise in Type 2 Diabetes.. Endocrinology 163(3) PMID: 35086144
- 8. Silva PN et al.. 2026. Polyadenylation of insulin mRNA by Tent5a regulates pancreatic beta cells.. Nat Commun 17(1) PMID: 42161934
